Literature DB >> 25416470

Sudden death in a case of megalencephaly capillary malformation associated with a de novo mutation in AKT3.

Atsuko Harada1, Fuyuki Miya, Hidetsuna Utsunomiya, Mitsuhiro Kato, Takumi Yamanaka, Tatsuhiko Tsunoda, Kenjiro Kosaki, Yonehiro Kanemura, Mami Yamasaki.   

Abstract

INTRODUCTION: Megalencephaly capillary malformation (MCAP) is a syndrome involving brain overgrowth, characterized by megalencephaly, capillary malformations, asymmetric growth, polymicrogyria, polydactyly, and syndactyly. Cerebellar tonsillar herniation (CTH) and ventriculomegaly are also observed in over half the patients with this syndrome. Early sudden death has been reported in MCAP, but its causes and the surgical strategies for its prevention remain unclear. CASE REPORT: Here, we report on a patient with MCAP who died suddenly at 5 months of age. He presented with progressive macrocephaly and hypotonia. MRI performed at 4 months of age showed tight posterior fossa, bilateral perisylvian polymicrogyria, enlargement of the straight sinus, and a thickened corpus callosum. However, since the patient did not exhibit capillary malformation, polydactyly, or syndactyly, a definitive diagnosis of MCAP could not be made. He died suddenly while asleep at home 1 month later. The sudden death of MCAP patients was previously attributed to CTH, convulsion, or arrhythmia. In this case, progressive cerebellar enlargement appeared to be the underlying cause. After the patient's death, using his preserved DNA, a missense mutation in the AKT3 gene was identified. Vakt murine thymoma viral oncogene homologue (AKT) is a serine-threonine kinase that functions in the mammalian target of rapamycin (mTOR) pathway and plays an important role in cell proliferation.
CONCLUSION: Accurate early diagnosis, including imaging and genetic analyses, and the recognition and treatment of critical conditions are required to prevent the sudden death of patients with MCAP.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25416470     DOI: 10.1007/s00381-014-2589-y

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  27 in total

1.  Macrocephaly-cutis marmorata telangiectatica congenita.

Authors:  Harold L Rekate
Journal:  J Neurosurg       Date:  2007-04       Impact factor: 5.115

2.  Association of arrhythmia and sudden death in macrocephaly-cutis marmorata telangiectatica congenita syndrome.

Authors:  S Yano; Y Watanabe
Journal:  Am J Med Genet       Date:  2001-08-01

3.  The role of nocturnal polysomnography in assessing children with Chiari type I malformation.

Authors:  Radhika Dhamija; Nicholas M Wetjen; Nancy L Slocumb; Jay Mandrekar; Suresh Kotagal
Journal:  Clin Neurol Neurosurg       Date:  2013-06-18       Impact factor: 1.876

4.  AKT3 and PIK3R2 mutations in two patients with megalencephaly-related syndromes: MCAP and MPPH.

Authors:  K Nakamura; M Kato; J Tohyama; T Shiohama; K Hayasaka; K Nishiyama; H Kodera; M Nakashima; Y Tsurusaki; N Miyake; N Matsumoto; H Saitsu
Journal:  Clin Genet       Date:  2013-06-10       Impact factor: 4.438

5.  Megalencephaly-capillary malformation (MCAP) and megalencephaly-polydactyly-polymicrogyria-hydrocephalus (MPPH) syndromes: two closely related disorders of brain overgrowth and abnormal brain and body morphogenesis.

Authors:  Ghayda M Mirzaa; Robert L Conway; Karen W Gripp; Tally Lerman-Sagie; Dawn H Siegel; Linda S deVries; Dorit Lev; Nancy Kramer; Elizabeth Hopkins; John M Graham; William B Dobyns
Journal:  Am J Med Genet A       Date:  2012-01-06       Impact factor: 2.802

Review 6.  A case of macrocephaly-cutis marmorata telangiectatica congenita and review of neuroradiologic features.

Authors:  Nevbahar Akcar; Baki Adapinar; Cagri Dinleyici; Beyhan Durak; I Ragip Ozkan
Journal:  Ann Genet       Date:  2004 Jul-Sep

7.  Hydrocephalus and Chiari type 1 malformation in macrocephaly-cutis marmorata telangiectatica congenita: a case-based update.

Authors:  Juan F Martínez-Lage; Encarna Guillén-Navarro; María-José Almagro; Matías Felipe-Murcia; Antonio López López-Guerrero; Marcelo Galarza
Journal:  Childs Nerv Syst       Date:  2009-09-10       Impact factor: 1.475

8.  Megalencephaly syndromes and activating mutations in the PI3K-AKT pathway: MPPH and MCAP.

Authors:  Ghayda M Mirzaa; Jean-Baptiste Rivière; William B Dobyns
Journal:  Am J Med Genet C Semin Med Genet       Date:  2013-04-16       Impact factor: 3.908

Review 9.  Macrocephaly-cutis marmorata telangiectatica congenita: report of six new patients and a review.

Authors:  Pablo Lapunzina; Alba Gairí; Alicia Delicado; M Angeles Mori; M Luisa de Torres; Anton Goma; Marcelo Navia; Isidora López Pajares
Journal:  Am J Med Genet A       Date:  2004-09-15       Impact factor: 2.802

10.  Endoscopic third ventriculostomy to treat hydrocephalus associated with macrocephaly-cutis marmorata telangiectatica congenita.

Authors:  Alim P Mitha; Kelly J Bullivant; Julie L Lauzon; Walter J Hader
Journal:  J Neurosurg Pediatr       Date:  2009-10       Impact factor: 2.375

View more
  3 in total

1.  Mutations of AKT3 are associated with a wide spectrum of developmental disorders including extreme megalencephaly.

Authors:  Diana Alcantara; Andrew E Timms; Karen Gripp; Laura Baker; Kaylee Park; Sarah Collins; Chi Cheng; Fiona Stewart; Sarju G Mehta; Anand Saggar; László Sztriha; Melinda Zombor; Oana Caluseriu; Ronit Mesterman; Margot I Van Allen; Adeline Jacquinet; Sofia Ygberg; Jonathan A Bernstein; Aaron M Wenger; Harendra Guturu; Gill Bejerano; Natalia Gomez-Ospina; Anna Lehman; Enrico Alfei; Chiara Pantaleoni; Valerio Conti; Renzo Guerrini; Ute Moog; John M Graham; Robert Hevner; William B Dobyns; Mark O'Driscoll; Ghayda M Mirzaa
Journal:  Brain       Date:  2017-10-01       Impact factor: 13.501

Review 2.  Proximal variants in CCND2 associated with microcephaly, short stature, and developmental delay: A case series and review of inverse brain growth phenotypes.

Authors:  Filomena Pirozzi; Benson Lee; Nicole Horsley; Deepika D Burkardt; William B Dobyns; John M Graham; Maria L Dentici; Claudia Cesario; Jens Schallner; Joseph Porrmann; Nataliya Di Donato; Pedro A Sanchez-Lara; Ghayda M Mirzaa
Journal:  Am J Med Genet A       Date:  2021-06-04       Impact factor: 2.802

3.  A combination of genetic and biochemical analyses for the diagnosis of PI3K-AKT-mTOR pathway-associated megalencephaly.

Authors:  Yutaka Negishi; Fuyuki Miya; Ayako Hattori; Yoshikazu Johmura; Motoo Nakagawa; Naoki Ando; Ikumi Hori; Takao Togawa; Kohei Aoyama; Kei Ohashi; Shinobu Fukumura; Seiji Mizuno; Ayako Umemura; Yoko Kishimoto; Nobuhiko Okamoto; Mitsuhiro Kato; Tatsuhiko Tsunoda; Mami Yamasaki; Yonehiro Kanemura; Kenjiro Kosaki; Makoto Nakanishi; Shinji Saitoh
Journal:  BMC Med Genet       Date:  2017-01-13       Impact factor: 2.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.